» Articles » PMID: 24192125

Pregnancy and Pharmacogenomics in the Context of Drug Metabolism and Response

Overview
Specialties Genetics
Pharmacology
Date 2013 Nov 7
PMID 24192125
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

It is well-known that profound physiological and biochemical changes occur throughout the course of pregnancy. At the same time, the role of pharmacogenomics in modulating the metabolism and response profile to numerous medications has been elucidated. Yet, the clinical impact of pharmacogenomics during pregnancy is less well understood. We present an overview of factors modulating the pharmacokinetics and pharmacodynamics of medications throughout the time span of pregnancy while providing insights on how pharmacogenomics may contribute to interindividual variability in drug metabolism and response amongst pregnant women.

Citing Articles

Impact of Microbiome on Hepatic Metabolizing Enzymes and Transporters in Mice during Pregnancy.

Han L, Wang L, Shi Y, Dempsey J, Pershutkina O, Dutta M Drug Metab Dispos. 2020; 48(8):708-722.

PMID: 32499338 PMC: 7434050. DOI: 10.1124/dmd.120.000039.


The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy.

Behura S, Dhakal P, Kelleher A, Balboula A, Patterson A, Spencer T Pharmacol Res. 2019; 149:104468.

PMID: 31600597 PMC: 6944055. DOI: 10.1016/j.phrs.2019.104468.


MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero.

Heinonen E, Szymanska-von Schultz B, Kaldo V, Nasiell J, Andersson E, Bergmark M BMJ Open. 2018; 8(8):e023281.

PMID: 30082365 PMC: 6078226. DOI: 10.1136/bmjopen-2018-023281.


Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.

Mutagonda R, Kamuhabwa A, Minzi O, Massawe S, Maganda B, Aklillu E Malar J. 2016; 15(1):278.

PMID: 27177586 PMC: 4866074. DOI: 10.1186/s12936-016-1327-1.


Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Ilekis J, Tsilou E, Fisher S, Abrahams V, Soares M, Cross J Am J Obstet Gynecol. 2016; 215(1 Suppl):S1-S46.

PMID: 26972897 PMC: 4925329. DOI: 10.1016/j.ajog.2016.03.001.